Heath C. Timmons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Heath C. Timmons has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alan H. Cherney
Drug Substance Technologies, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States
1 shared publication Alexandra L. Perri
1 shared publicationArmela O. Dicu
1 shared publication- Austin Gerald Smith
Pivotal & Commercial Synthetics, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California91320, United States
1 shared publication Cynthia Elias
1 shared publication- Daniel J. Griffin
Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States
1 shared publication
Latest Publications
- 16 November 2007
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (49) , 14225-14231
Substrate Chirality and Specificity of Diacylglycerol Kinases and the Multisubstrate Lipid Kinase
The α, ζ, and ε isoforms of diacylglycerol kinase exhibit a high degree of stereospecificity in the phosphorylation of diacylglycerol. In comparison, a multiple lipid kinase, MuLK, shows much less stereospecificity, phosphorylating 1,2-dioleoylglycerol only ∼2−3 times more rapidly than 2,3-dioleoylglycerol. The α and ζ isoforms of diacylglycerol kinase are inhibited by 2,3-dioleoylglycerol, but not the more substrate-selective ε isoform. The inhibition by 2,3-dioleoylglycerol is uncompetitive. This corresponds to a kinetic scheme in which the inhibitor can bind to the enzyme−substrate complex, but not to the free enzyme. Our data indicate that despite their similar structures, 1,2-dioleoylglycerol and 2,3-dioleoylglycerol do not compete for the active site of these three isoforms of diacylglycerol kinase. We suggest that the 2,3-dioleoylglycerol binds to a site on the α and ζ isoforms of diacylglycerol kinase that is exposed as a consequence of the substrate binding to the active site. The chiral specificity of these enzymes thus mimics the substrate specificity, with MuLK being the least selective and the ε isoform of diacylglycerol kinase exhibiting the greatest selectivity.
- 16 November 2007
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (49) , 14225-14231
Substrate Chirality and Specificity of Diacylglycerol Kinases and the Multisubstrate Lipid Kinase
The α, ζ, and ε isoforms of diacylglycerol kinase exhibit a high degree of stereospecificity in the phosphorylation of diacylglycerol. In comparison, a multiple lipid kinase, MuLK, shows much less stereospecificity, phosphorylating 1,2-dioleoylglycerol only ∼2−3 times more rapidly than 2,3-dioleoylglycerol. The α and ζ isoforms of diacylglycerol kinase are inhibited by 2,3-dioleoylglycerol, but not the more substrate-selective ε isoform. The inhibition by 2,3-dioleoylglycerol is uncompetitive. This corresponds to a kinetic scheme in which the inhibitor can bind to the enzyme−substrate complex, but not to the free enzyme. Our data indicate that despite their similar structures, 1,2-dioleoylglycerol and 2,3-dioleoylglycerol do not compete for the active site of these three isoforms of diacylglycerol kinase. We suggest that the 2,3-dioleoylglycerol binds to a site on the α and ζ isoforms of diacylglycerol kinase that is exposed as a consequence of the substrate binding to the active site. The chiral specificity of these enzymes thus mimics the substrate specificity, with MuLK being the least selective and the ε isoform of diacylglycerol kinase exhibiting the greatest selectivity.